Skip to main content

Table 2 Baseline associations of serum and dialysate electrolytes with QTc interval in 330 incident dialysis patients

From: Associations of serum and dialysate electrolytes with QT interval and prolongation in incident hemodialysis: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study

Variables

Model 1

Model 2

Model 3

QTc difference (95% CI), ms

P

QTc difference (95% CI), ms

P

QTc difference (95% CI), ms

P

Serum measurements

 Total calcium, per 1 mg/dl decrease

+ 3.23 (−4.44, 10.89)

0.41

+ 4.46 (− 2.84, 11.75)

0.23

+ 2.70 (− 4.67, 10.06)

0.47

 Corrected calcium, per 1 mg/dl decrease

+ 2.27 (−6.48, 11.03)

0.61

+ 3.46 (− 4.89, 11.80)

0.42

+ 1.56 (− 6.65, 9.77)

0.71

 Ionized calciuma, per 0.1 mmol/l decrease

+ 9.77 (2.97, 16.57)

0.01

+ 10.32 (3.87, 16.78)

0.002

+ 8.55 (2.13, 14.97)

0.01

 Potassium, per 1 mEq/l decrease

+ 11.08 (2.18, 19.98)

0.02

+ 10.97 (2.50, 19.43)

0.01

+ 9.89 (1.58, 18.20)

0.02

 Magnesiuma, per 0.1 mEq/l decrease

+ 0.34 (− 1.73, 2.40)

0.75

+ 0.35 (− 1.61, 2.31)

0.73

− 0.21 (− 2.13, 1.72)

0.83

Dialysate measurements

 Calcium

  2.5 mEq/l

reference

 

reference

 

reference

 

  < 2.5 mEq/l

+ 1.27 (− 8.70, 11.24)

0.80

− 0.90 (− 10.55, 8.74)

0.86

+ 0.95 (− 8.52, 10.42)

0.84

 Potassium

  2 mEq/l

reference

 

reference

 

reference

 

  > 2 mEq/l

−2.73 (− 16.96, 11.49)

0.71

−3.53 (− 17.01, 9.94)

0.61

−3.98 (− 17.16, 9.21)

0.56

Serum-to-dialysate gradients

 Total calcium, per 1 mEq/l increase in difference

−3.33 (− 15.22, 8.55)

0.58

−6.84 (− 18.30, 4.62)

0.24

− 3.04 (− 14.57, 8.49)

0.61

 Corrected calcium, per 1 mEq/l increase in difference

− 1.81 (− 14.66, 11.03)

0.78

− 5.40 (− 17.82, 7.02)

0.40

− 1.44 (− 13.72, 10.83)

0.82

  1. Model 1 includes the main exposure (one of serum, dialysate, or gradient measurements)
  2. Model 2 includes model 1, age, sex, and ethnicity
  3. Model 3 includes model 2, Charlson comorbidity index, non-dialysis systolic blood pressure, left ventricular mass index, and use of antihypertensive medication, renin-angiotensin-aldosterone system blockade, cinacalcet, and QT-prolonging medication
  4. aModels with ionized calcium and magnesium also include serum pH